2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide
C18H23N9O — CID 59199580
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide
2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide (PubChem CID 59199580) has the molecular formula C18H23N9O and a molecular weight of 381.44 g/mol. Its IUPAC name is 2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | 2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide |
|---|---|
| PubChem CID | 59199580 |
| Molecular Formula | C18H23N9O |
| Molecular Weight | 381.44 g/mol |
| Exact Mass | 381.20 |
| IUPAC Name | 2-[[(2R)-1-amino-3-methylbutan-2-yl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide |
| SMILES | CC(C)[C@H](CN)Nc1ncc(C(N)=O)c(Nc2cccc(-n3nccn3)c2)n1 |
| InChI | InChI=1S/C18H23N9O/c1-11(2)15(9-19)25-18-21-10-14(16(20)28)17(26-18)24-12-4-3-5-13(8-12)27-22-6-7-23-27/h3-8,10-11,15H,9,19H2,1-2H3,(H2,20,28)(H2,21,24,25,26)/t15-/m0/s1 |
| InChIKey | PPUHIHGKJAJBQH-HNNXBMFYSA-N |
| XLogP | 1.29 |
| TPSA | 149.66 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 381.44 |
| LogP ≤ 5 | 1.29 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59199580 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.